Shopping Cart
0 Item in Cart

Optimization of Pharmaceutical R&D Programs and Portfolios
Click for related books: Antonijevic

Rating  
(80 Ratings)

Retail Price: 8329.00/-
Price: 6247.00/-
Inclusive all taxes
25.00% OFF
Sold By: Store4Doctors

Offer 1: Get 25.00% + Flat ₹ 50 discount on shopping of ₹ 1500
                use code:
MPSTK50

Offer 2: Get 25.00% + Flat ₹ 150 discount on shopping of
                ₹ 5000 use code:
MPSTK150

Free Shipping (for orders above ₹ 499)  *T&C apply.

In Stock Click For New Edition
Select Quantity :



Description

Very little has been published on optimization of pharmaceutical portfolios. Moreover, most of published literature is coming from the commercial side, where probability of technical success (PoS) is treated as fixed, and not as a consequence of development strategy or design. In this book there is a strong focus on impact of study design on PoS and ultimately on the value of portfolio. Design options that are discussed in different chapters are dose-selection strategies, adaptive design and enrichment. Some development strategies that are discussed are indication sequencing, optimal number of programs and optimal decision criteria. This book includes chapters written by authors with very broad backgrounds including financial, clinical, statistical, decision sciences, commercial and regulatory. Many authors have long held executive positions and have been involved with decision making at a product or at a portfolio level. As such, it is expected that this book will attract a very broad audience, including decision makers in pharmaceutical R&D, commercial and financial departments. The intended audience also includes portfolio planners and managers, statisticians, decision scientists and clinicians. Early chapters describe approaches to portfolio optimization from big Pharma and Venture Capital standpoints. They have stronger focus on finances and processes. Later chapters present selected statistical and decision analysis methods for optimizing drug development programs and portfolios. Some methodological chapters are technical; however, with a few exceptions they require a relatively basic knowledge of statistics by a reader.

More Details About Optimization of Pharmaceutical R&D Programs and Portfolios
General Information
Author(s)Antonijevic
PublisherSpringer
Edition1
ISBN9783319090740
Pages202
BindingHard Bound
LanguageEnglish
Publish YearJanuary 2014
Reviews of Optimization of Pharmaceutical R&D Programs and Portfolios
Average Rating

Write A Review

TOP REVIEWS


Top Reviews lists the most relevant product reviews only.


RECENT TOP REVIEWS